MedPath

Ferric carboxymaltose

Generic Name
Ferric carboxymaltose
Brand Names
Injectafer
Drug Type
Small Molecule
CAS Number
9007-72-1
Unique Ingredient Identifier
6897GXD6OE

Overview

Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.

Background

Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.

Indication

Ferric carboxymaltose is an iron replacement product indicated for the treatment of iron deficiency anemia in patients ≥1 year of age who have an intolerance to, or unsatisfactory response from, oral iron therapy. It is also indicated in adult patients who have non-dialysis-dependent chronic kidney disease.

Associated Conditions

  • Iron Deficiency Anemia (IDA)

Clinical Trials

FDA Approved Products

Injectafer
Manufacturer:American Regent, Inc.
Route:INTRAVENOUS
Strength:50 mg in 1 mL
Approved: 2023/06/06
NDC:0517-0650
Injectafer
Manufacturer:American Regent, Inc.
Route:INTRAVENOUS
Strength:50 mg in 1 mL
Approved: 2023/06/06
NDC:0517-0602
Injectafer
Manufacturer:American Regent, Inc.
Route:INTRAVENOUS
Strength:50 mg in 1 mL
Approved: 2023/06/06
NDC:0517-0620

Singapore Approved Products

Ferinject Solution for Injection 50mg/ml
Manufacturer:IDT Biologika GmbH
Form:INJECTION, SOLUTION
Strength:50 mg/ml
Online:Yes
Approved: 2011/10/19
Approval:SIN14035P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath